Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program
HAYWARD, Calif., Jan. 23, 2023. Benitec Biopharma Inc. (“Benitec” or“the Company”), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA-directed...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Biotechnology | Clinical Trials | Gene Therapy | Genetics | Pharmaceuticals